Also categorized in BoardMoves:
PepsiCo Puts Trian Business Advisor On Board
x hide permanently

Peter Svennilson Elected to RAPT Therapeutics Board of Directors


RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced the election of Peter Svennilson, Managing Partner of The Column Group, to its Board of Directors...

Mentions: Nasdaq RAPT Therapeutics Board of Directors